1-109228441-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006513.4(SARS1):c.288+9T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.775 in 1,589,930 control chromosomes in the GnomAD database, including 483,476 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.70 ( 39251 hom., cov: 32)
Exomes 𝑓: 0.78 ( 444225 hom. )
Consequence
SARS1
NM_006513.4 intron
NM_006513.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.623
Genes affected
SARS1 (HGNC:10537): (seryl-tRNA synthetase 1) This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. [provided by RefSeq, Jul 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-109228441-T-C is Benign according to our data. Variant chr1-109228441-T-C is described in ClinVar as [Benign]. Clinvar id is 1327978.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.872 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SARS1 | NM_006513.4 | c.288+9T>C | intron_variant | ENST00000234677.7 | NP_006504.2 | |||
SARS1 | NM_001330669.1 | c.288+9T>C | intron_variant | NP_001317598.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARS1 | ENST00000234677.7 | c.288+9T>C | intron_variant | 1 | NM_006513.4 | ENSP00000234677.2 | ||||
SARS1 | ENST00000369923.4 | c.288+9T>C | intron_variant | 5 | ENSP00000358939.4 | |||||
SARS1 | ENST00000477544.5 | n.313+9T>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.703 AC: 106853AN: 151982Hom.: 39240 Cov.: 32
GnomAD3 genomes
AF:
AC:
106853
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.768 AC: 191370AN: 249204Hom.: 74816 AF XY: 0.766 AC XY: 103263AN XY: 134744
GnomAD3 exomes
AF:
AC:
191370
AN:
249204
Hom.:
AF XY:
AC XY:
103263
AN XY:
134744
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.783 AC: 1125252AN: 1437830Hom.: 444225 Cov.: 25 AF XY: 0.780 AC XY: 559296AN XY: 716830
GnomAD4 exome
AF:
AC:
1125252
AN:
1437830
Hom.:
Cov.:
25
AF XY:
AC XY:
559296
AN XY:
716830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.703 AC: 106901AN: 152100Hom.: 39251 Cov.: 32 AF XY: 0.702 AC XY: 52158AN XY: 74350
GnomAD4 genome
AF:
AC:
106901
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
52158
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2624
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Neurodevelopmental disorder with microcephaly, ataxia, and seizures Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at